Roivant Won’t Continue With Brepocitinib In Lupus After Phase II Failure

 
• By Joseph Haas
Juggling
Without SLE, Roivant has fewer indications to juggle now with brepocitinib • Source: Shutterstock

More from Clinical Trials

More from R&D